MPS Pharmaa Limited

₹2.08As of Sun 8 Nov 2026, 12:00 UTC
BSE:531686Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (10.75%)
Div yield —
ROE (177.51%)
Pharmaceutical Preparations
Beta (5Y) —
PE TTM —
TSR TTM 4.52%
Mkt cap ₹39.75M
ROIC (7.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2.24
7.62%
596.36%
Hold 8|9|12|10|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.04
0.04
0.04
0.05
17.96%
26.82%
31.50%
36.40%
Revenue₹M
3.643
3.663
3.580
3.708
(3.12%)
(0.80%)
(2.32%)
2.40%
Peers (US$0.423M)
Cap (US$)
PE
0.630M
213.3x
Capital
TTM
5Y
10Y
Leveragex
0.184
(0.173)
(0.158)
EBIT/Intx
0.708
0.356
0.302
Own earn%
(224.13)
(35.94)
(32.46)
Sh yield%
31.27
27.80
30.54
Owners
Insiders/Inst%
7.26
40.37
Short interest%
4.92
SBC / revenue%
1.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
0–8
$1 testx
0.0
Incr. ROIC%
6